Morphosys Ag (MOR) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
MorphoSys AG has announced a delisting agreement with Novartis, following the latter’s successful acquisition and intent to merge with MorphoSys. Novartis, now holding over 91% of MorphoSys shares, plans to offer the remaining shareholders €68.00 per share to consolidate ownership. The transaction processes, including the delisting from Frankfurt Stock Exchange and NASDAQ, are expected to be completed in the third quarter of 2024.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
